Business
Divi’s Laboratories Q4 Result FY26: API Recovery Drives a Strong Earnings Comeback
The long wait for pharmaceutical investors is finally over as Divi’s Laboratories Limited announced its Q4 FY26 results on May…
Business
Gland Pharma Q4 Result FY26: Profit Doubles, Margins Expand and the Turnaround Story Gets Stronger
Introduction: Gland Pharma’s Blowout Quarter Changes Market Sentiment Injectables major Gland Pharma delivered one of the strongest pharmaceutical earnings surprises…